Bright Minds Biosciences (DRUG) Shares Outstanding (Diluted Average) (2020 - 2025)
For the quarter ending Q3 2024, Shares Outstanding (Diluted Average) rose 13.87% year-over-year to $3.2 million, compared with a TTM value of $3.2 million through Sep 2024, up 13.87%, and an annual FY2024 reading of $3.2 million, up 13.87% over the prior year.
Bright Minds Biosciences (DRUG) has disclosed Shares Outstanding (Diluted Average) for 4 consecutive years, with $3.2 million as the latest value for Q3 2024.
- Shares Outstanding (Diluted Average) reached $3.2 million in Q3 2024 per DRUG's latest filing, up from $2.8 million in the prior quarter.
- Across five years, Shares Outstanding (Diluted Average) topped out at $3.2 million in Q3 2024 and bottomed at $1.4 million in Q3 2021.
- Average Shares Outstanding (Diluted Average) over 4 years is $2.3 million, with a median of $2.3 million recorded in 2022.
- Year-over-year, Shares Outstanding (Diluted Average) skyrocketed 46.49% in 2023 and then rose 13.87% in 2024.
- Bright Minds Biosciences' Shares Outstanding (Diluted Average) stood at $1.4 million in 2021, then soared by 32.85% to $1.9 million in 2022, then surged by 46.49% to $2.8 million in 2023, then grew by 13.87% to $3.2 million in 2024.
- Per Business Quant, the three most recent readings for DRUG's Shares Outstanding (Diluted Average) are $3.2 million (Q3 2024), $2.8 million (Q3 2023), and $1.9 million (Q3 2022).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 3.06 Mn |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 810.00 |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | 118.76 Bn |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 256.30 Mn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 107.70 Mn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 138.23 Mn |
| 10 | Bright Minds Biosciences | 464.72 Mn | 405.19 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5.57 Mn |
| Jun 30, 2025 | 5.11 Mn |
| Mar 31, 2025 | 4.91 Mn |
| Dec 31, 2024 | 7.16 |
| Sep 30, 2024 | 124.62 |
| Jun 30, 2024 | 36.56 |
| Mar 31, 2024 | 3.31 Mn |
| Dec 31, 2023 | 2.82 Mn |
| Sep 30, 2023 | 2.77 Mn |
| Jun 30, 2023 | 2.81 Mn |
| Mar 31, 2023 | 406.83 |
| Dec 31, 2022 | 478.86 |
| Sep 30, 2022 | 1.89 Mn |
| Jun 30, 2022 | 9.30 Mn |
| Mar 31, 2022 | 9.35 Mn |
| Dec 31, 2021 | 9.39 Mn |
| Sep 30, 2021 | 1.43 Mn |
| Jun 30, 2021 | 9.21 Mn |
| Mar 31, 2021 | 5.47 Mn |
| Dec 31, 2020 | 4.44 Mn |